BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2414240)

  • 1. Florid mesonephric hyperplasia of the cervix: a report of a case with review of the literature.
    Ayroud Y; Gelfand MM; Ferenczy A
    Int J Gynecol Pathol; 1985; 4(3):245-54. PubMed ID: 2414240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. A study of 49 cases.
    Ferry JA; Scully RE
    Am J Surg Pathol; 1990 Dec; 14(12):1100-11. PubMed ID: 2252101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesonephric rest hyperplasia. A potential diagnostic pitfall.
    Amin-Hanjani S; Paulson J; Henien S; Hanjani P
    Arch Pathol Lab Med; 1991 Oct; 115(10):1059-61. PubMed ID: 1898238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesonephric adenocarcinoma (endometrioid type) of endocervix with diffuse mesonephric hyperplasia involving cervical wall and myometrium: an unusual case report.
    Menon S; Kathuria K; Deodhar K; Kerkar R
    Indian J Pathol Microbiol; 2013; 56(1):51-3. PubMed ID: 23924560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
    Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
    Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The histogenetic origin of cervical mesonephric hyperplasia and mesonephric adenocarcinoma of the uterine cervix studied with immunohistochemical methods.
    Lang G; Dallenbach-Hellweg G
    Int J Gynecol Pathol; 1990; 9(2):145-57. PubMed ID: 1692008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical Mesonephric Adenocarcinoma With Novel FGFR2 Mutation.
    Skala SL; Gregg PA; Orr JW; Udager AM; Brown NA; Cho KR
    Int J Gynecol Pathol; 2020 Sep; 39(5):452-455. PubMed ID: 31335448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesonephric adenocarcinoma in the uterine corpus: A case report and review of the literature.
    Tang X; Li L; He Y
    Indian J Pathol Microbiol; 2021; 64(4):806-809. PubMed ID: 34673610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesonephric remnant hyperplasia of the cervix: a clinicopathologic analysis of 14 cases.
    Jones MA; Andrews J; Tarraza HM
    Gynecol Oncol; 1993 Apr; 49(1):41-7. PubMed ID: 8482559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical adenocarcinoma arising in florid mesonephric hyperplasia: report of a case with immunocytochemical studies.
    Valente PT; Susin M
    Gynecol Oncol; 1987 May; 27(1):58-68. PubMed ID: 2436982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopathological study of mesonephric lesions of cervix uteri and vagina.
    Kondi-Pafitis A; Kairi E; Kontogianni KI; Dimopoulou C; Sikiotis K; Smyrniotis V
    Eur J Gynaecol Oncol; 2003; 24(2):154-6. PubMed ID: 12701967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesonephric adenocarcinoma of the uterine cervix with focal endocrine cell differentiation.
    Stewart CJ; Taggart CR; Brett F; Mutch AF
    Int J Gynecol Pathol; 1993 Jul; 12(3):264-9. PubMed ID: 7688354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
    McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
    Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesonephric adenocarcinoma of the uterine corpus: CD10 expression as evidence of mesonephric differentiation.
    Ordi J; Nogales FF; Palacin A; Márquez M; Pahisa J; Vanrell JA; Cardesa A
    Am J Surg Pathol; 2001 Dec; 25(12):1540-5. PubMed ID: 11717545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity of four lectins for endocervical and endometrial non-neoplastic and neoplastic glandular epithelium.
    Toda T; Sadi AM; Egawa H; Atari E; Qureshi B; Nagai Y
    Histopathology; 1998 Mar; 32(3):257-63. PubMed ID: 9568512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesonephric adenocarcinoma of the cervix: a case report with a three-year follow-up, lung metastases, and next-generation sequencing analysis.
    Montalvo N; Redrobán L; Galarza D
    Diagn Pathol; 2019 Jul; 14(1):71. PubMed ID: 31266530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urethral obstruction due to lobular mesonephric hyperplasia of the vagina--a case report.
    Handoo A; Kini H; Pai R; Prabhu GG
    Indian J Pathol Microbiol; 2005 Jan; 48(1):20-1. PubMed ID: 16758778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesonephric hyperplasia of the uterine cervix: a clinicopathologic study of 51 cases.
    Seidman JD; Tavassoli FA
    Int J Gynecol Pathol; 1995 Oct; 14(4):293-9. PubMed ID: 8598330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic quiz case: an incidentally detected mass of the uterine cervix. Mesonephric adenocarcinoma of the cervix.
    Angeles RM; August CZ; Weisenberg E
    Arch Pathol Lab Med; 2004 Oct; 128(10):1179-80. PubMed ID: 15387698
    [No Abstract]   [Full Text] [Related]  

  • 20. Carcinosarcoma of the uterine cervix: a rare pathological finding originating from mesonephric remnants.
    Ribeiro B; Silva R; Dias R; Patrício V
    BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30936330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.